about
Intrinsic Order and Disorder in the Bcl-2 Member Harakiri: Insights into Its Proapoptotic ActivityUnderstanding the antagonism of retinoblastoma protein dephosphorylation by PNUTS provides insights into the PP1 regulatory codeRole of serine-threonine phosphoprotein phosphatases in smooth muscle contractilityPlasmodium falciparum inhibitor-3 homolog increases protein phosphatase type 1 activity and is essential for parasitic survivalOrder and disorder in large multi-site docking proteins of the Gab family--implications for signalling complex formation and inhibitor design strategiesEnsemble modeling of protein disordered states: experimental restraint contributions and validation.Domain cooperativity in multidomain proteins: what can we learn from molecular alignment in anisotropic media?Comparison of structure determination methods for intrinsically disordered amyloid-β peptides.Characterization of disordered proteins with ENSEMBLE.Protein phosphatase 1 β paralogs encode the zebrafish myosin phosphatase catalytic subunitViewing serine/threonine protein phosphatases through the eyes of drug designersDynamic Protein Interaction Networks and New Structural Paradigms in Signaling.Structural basis for protein phosphatase 1 regulation and specificityFolding of Intrinsically Disordered Protein Phosphatase 1 Regulatory Proteins.Regulation of protein phosphatase 1 by intrinsically disordered proteinsHow random are intrinsically disordered proteins? A small angle scattering perspective.Conformational propensities of intrinsically disordered proteins from NMR chemical shifts.NMR contributions to structural dynamics studies of intrinsically disordered proteinsExpression of MYPT1, CPI-17 and MLC20 in ileum of neonatal mouse NEC model and its significance.Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding.Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.Overexpression of Myosin Phosphatase Target Subunit 1 (MYPT1) Inhibits Tumor Progression and Metastasis of Gastric Cancer.Structural characterization by nuclear magnetic resonance of the impact of phosphorylation in the proline-rich region of the disordered Tau protein.
P2860
Q27670693-D1541D42-5501-496E-A38F-38ACFAA7913BQ27681976-3FA70BAE-2C87-4387-A0BE-31BB89952B7BQ27693957-C0ECF64E-5831-4D61-A03C-1D0BC733C439Q27973484-1DEB0FC9-E999-43DB-9809-FBCF04C5A92DQ28248627-E03A1960-6995-40FC-84F7-4DCA4AFDF5EDQ30010207-6570A8FA-055A-4D6C-B512-67F6931595F8Q30010233-49E27FB5-0493-40A0-88A6-8E617206BEF1Q33791740-16E89B9E-49D5-4D9B-AE98-E868A47262A4Q34317134-52B980C6-36BF-44D8-81F5-466302DC83F8Q34990649-AF28E3DB-F361-40DA-ABD4-C8C5DFABCF4FQ35146774-D13FF83B-AE7E-4686-A76A-8869A1CB533EQ35938545-99360295-7F79-43DA-BD0A-0784941F56BBQ35954007-D48236B1-1ABC-4301-88A5-8464D3DFD455Q36132363-683A365D-9075-4C4A-BACE-EF8BAC8DD9CBQ36413937-6EC48F14-4240-4079-9BCB-6EC4CA89423AQ37951586-30323CDD-02E0-4939-AAB3-ECF1971EE326Q38116495-07FF36EC-C761-4614-8BD0-AAC191372085Q38198240-7051CF10-598F-45D6-AB49-CA4D9C0E9AA9Q41672266-8A446720-DD0A-4799-A468-E5D4F6CC64CBQ42053910-7E3F5347-8790-40AC-BF18-63D667B8F3D5Q45949486-050B6B49-F897-4733-B4F2-3FAE08312080Q52717140-6F71DE2A-8823-4A69-BE18-3C47607B0DEDQ53323738-B0293407-FBF0-4CF0-B870-AC003BEC9492
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Structural signature of the MYPT1-PP1 interaction.
@en
type
label
Structural signature of the MYPT1-PP1 interaction.
@en
prefLabel
Structural signature of the MYPT1-PP1 interaction.
@en
P2860
P50
P356
P1476
Structural signature of the MYPT1-PP1 interaction
@en
P2093
Wolfgang Peti
P2860
P356
10.1021/JA107810R
P407
P577
2010-12-10T00:00:00Z